Oxford Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,153
Closed -$223K – 525
2026
Q1
$223K Buy
+3,153
New +$236K 0.09% 337
2025
Q2
– Sell
-4,750
Closed -$381K – 664
2025
Q1
$381K Buy
+4,750
New +$395K 0.17% 202
2024
Q3
– Sell
-2,880
Closed -$202K – 394
2024
Q2
$202K Buy
+2,880
New +$206K 0.2% 211
2019
Q4
– Sell
-22,041
Closed -$1.04M – 1956
2019
Q3
$1.04M Buy
+22,041
New +$1.05M 0.03% 929
2019
Q2
– Sell
-28,417
Closed -$1.21M – 1866
2019
Q1
$1.21M Buy
+28,417
New +$1.26M 0.03% 835
2018
Q1
– Sell
-138,458
Closed -$7.04M – 1784
2017
Q4
$7.04M Buy
+138,458
New +$7.29M 0.15% 146

Other funds holding MET

Oxford Asset Management's MET Position: Q2 2026 in Review

Oxford Asset Management sold out of MetLife (MET) in Q2 2026, closing a stake of 3,153 shares — an estimated $223K sold.

Oxford Asset Management first reported a position in MET in Q4 2017 and held it in 6 quarters. The position peaked at $7.04M in Q4 2017. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Oxford Asset Management reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Oxford Asset Management sold 3,153 MetLife shares in Q2 2026, an estimated $223K.
  • Oxford Asset Management first reported a position in MetLife in Q4 2017 and held it in 6 quarters.
  • Oxford Asset Management's MetLife position peaked at $7.04M in Q4 2017.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.